Q4 2022 Holdings
Filed 2023-02-13 | 63 holdings | $255.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $21.4M | 818,035 | 8.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $20.3M | 70,000 | 8.0% |
| Bristol Myers Squibb Co(BMY)Put | COM | 110122108 | $12.6M | 175,000 | 4.9% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $12.5M | 190,767 | 4.9% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $8.7M | 70,997 | 3.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.3M | 80,000 | 3.2% |
| Prometheus Biosciences Inc | COM | 74349U108 | $8.3M | 75,000 | 3.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADR | 925050106 | $8.2M | 312,498 | 3.2% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $7.9M | 240,623 | 3.1% |
| Morphic Hldg Inc | COM | 61775R105 | $7.5M | 280,921 | 2.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $7.4M | 240,143 | 2.9% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $7.2M | 1,143,531 | 2.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $7.0M | 472,482 | 2.8% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $6.8M | 215,000 | 2.7% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $5.7M | 90,000 | 2.2% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $5.4M | 30,000 | 2.1% |
| Amgen Inc(AMGN)Put | COM | 031162100 | $5.3M | 20,000 | 2.1% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $5.1M | 45,000 | 2.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.1M | 258,115 | 2.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.9M | 110,000 | 1.9% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $4.7M | 573,678 | 1.8% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.1M | 60,000 | 1.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.0M | 87,601 | 1.6% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $3.9M | $10,000,000 | 1.5% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $3.4M | $7,500,000 | 1.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.3M | 268,747 | 1.3% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $3.3M | 350,000 | 1.3% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $3.1M | 60,630 | 1.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $2.9M | 60,000 | 1.1% |
| Verona Pharma PLC(VRNA)Call | SPONSORED ADS | 925050106 | $2.7M | 105,000 | 1.1% |
| Geron Corp(GERN)Put | COM | 374163103 | $2.6M | 1,056,500 | 1.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.5M | 100,000 | 1.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $2.4M | 375,000 | 0.9% |
| Viking Therapeutics Inc(VKTX)Call | COM | 92686J106 | $2.4M | 250,000 | 0.9% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $2.2M | 661,264 | 0.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.2M | 193,064 | 0.9% |
| Point Biopharma Global Inc | COM | 730541109 | $2.2M | 303,218 | 0.9% |
| Novavax Inc(NVAX)Put | COM NEW | 670002401 | $2.1M | 200,000 | 0.8% |
| Geron Corp(GERN)Call | COM | 374163103 | $2.0M | 837,000 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.0M | 50,000 | 0.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $1.9M | 5,000 | 0.7% |
| Novocure LTD(NVCR)Call | ORD SHS | G6674U108 | $1.8M | 25,000 | 0.7% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $1.8M | 247,891 | 0.7% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $1.5M | 1,492,771 | 0.6% |
| Precigen Inc | NOTE 3.500% 7/0 | 46122TAA0 | $1.5M | $1,500,000 | 0.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $1.4M | 460,328 | 0.6% |
| Esperion Therapeutics Inc NE | NOTE 4.000%11/1 | 29664WAB1 | $1.4M | $2,500,000 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.3M | 188,292 | 0.5% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $1.2M | 150,000 | 0.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.1M | 92,170 | 0.4% |